Influence of saliva on the oral microbiota

Periodontology 2000

Volumn 70, Issue 1, 2016, Pages 80-92

  Marsh, Philip D ^a   Do, Thuy ^a   Beighton, David ^a   Devine, Deirdre A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

SALIVA PROTEIN;

CHEMISTRY; HUMAN; METABOLISM; MICROBIOLOGY; MICROFLORA; MOUTH; PHYSIOLOGY; SALIVA;

HUMANS; MICROBIOTA; MOUTH; SALIVA; SALIVARY PROTEINS AND PEPTIDES;

EID: 84949656937     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/prd.12098     Document Type: Review

References (114)

1. Abdolhosseini M, Sotsky JB, Shelar AP, Joyce PB, Gorr SU. Human parotid secretory protein is a lipopolysaccharide-binding protein: identification of an anti-inflammatory peptide domain. Mol Cell Biochem 2012: 359: 1-8.
2. Ahn SJ, Kho HS, Lee SW, Nahm DS. Roles of salivary proteins in the adherence of oral streptococci to various orthodontic brackets. J Dent Res 2002: 81: 411-415.
3. Al Kawas S, Rahim ZH, Ferguson DB. Potential uses of human salivary protein and peptide analysis in the diagnosis of disease. Arch Oral Biol 2012: 57: 1-9.
4. Alalwani SM, Sierigk J, Herr C, Pinkenberg O, Gallo R, Vogelmeier C, Bals R. The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils. Eur J Immunol 2010: 40: 1118-1126.
5. Amado F, Lobo MJC, Domingues P, Duarte JA, Vitorino R. Salivary peptidomics. Expert Rev Proteomics 2010: 7: 709-721.
6. Ambatipudi KS, Lu BW, Hagen FK, Melvin JE, Yates JR. Quantitative analysis of age specific variation in the abundance of human female parotid salivary proteins. J Proteome Res 2009: 8: 5093-5102.
7. Andrian E, Qi GF, Wang J, Halperin SA, Lee SF. Role of surface proteins SspA and SspB of Streptococcus gordonii in innate immunity. Microbiology 2012: 158: 2099-2106.
8. Arslan SY, Leung KP, Wu CD. The effect of lactoferrin on oral bacterial attachment. Oral Microbiol Immunol 2009: 24: 411-416.
9. Bachrach G, Altman H, Kolenbrander PE, Chalmers NI, Gabai-Gutner M, Mor A, Friedman M, Steinberg D. Resistance of Porphyromonas gingivalis ATCC 33277 to direct killing by antimicrobial peptides is protease independent. Antimicrob Agents Chemother 2008: 52: 638-642.
10. Baik JE, Hong SW, Choi S, Jeon JH, Park OJ, Cho K, Seo DG, Kum KY, Yun CH, Han SH. Alpha-amylase is a human salivary protein with affinity to lipopolysaccharide of Aggregatibacter actinomycetemcomitans. Mol Oral Microbiol 2013: 28: 142-153.
11. Bang C, Schilhabel A, Weidenbach K, Kopp A, Goldmann T, Gutsmann T, Schmitz RA. Effects of antimicrobial peptides on methanogenic archaea. Antimicrob Agents Chemother 2012: 56: 4123-4130.
12. Bercier JG, Al-Hashimi I, Haghighat N, Rees TD, Oppenheim FG. Salivary histatins in patients with recurrent oral candidiasis. J Oral Path Med 1999: 28: 26-29.
13. Bevins CL, Salzman NH. The potter's wheel: the host's role in sculpting its microbiota. Cell Mol Life Sci 2011: 68: 3675-3685.
14. Bradshaw D, Marsh P. Analysis of pH-driven disruption of oral microbial communities in vitro. Caries Res 1998: 32: 456-462.
15. Bradshaw DJ, Homer KA, Marsh PD, Beighton D. Metabolic cooperation in oral microbial communities during growth on mucin. Microbiology 1994: 140: 3407-3412.
16. Brady LJ, Maddocks SE, Larson MR, Forsgren N, Persson K, Deivanayagam CC, Jenkinson HF. The changing faces of Streptococcus antigen I/II polypeptide family adhesins. Mol Microbiol 2010: 77: 276-286.
17. Brissette CA, Lukehart SA. Mechanisms of decreased susceptibility to beta-defensins by Treponema denticola. Infect Immun 2007: 75: 2307-2315.
18. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 2005: 3: 238-250.
19. Brown KL, Hancock REW. Cationic host defense (antimicrobial) peptides. Curr Opin Immunol 2006: 18: 24-30.
20. Busscher HJ, Norde W, van der Mei HC. Specific molecular recognition and nonspecific contributions to bacterial interaction forces. Appl Environ Microbiol 2008: 74: 2559-2564.
21. Byers HL, Homer KA, Beighton D. Utilization of sialic acid by viridans streptococci. J Dent Res 1996: 75: 1564-1571.
22. Cabras T, Pisano E, Montaldo C, Giuca MR, Lavarone F, Zampino G, Castagnola M, Messana I. Significant modifications of the salivary proteome potentially associated with complications of Down Syndrome revealed by top-down proteomics. Mol Cell Proteomics 2013: 12: 1844-1852.
23. Campo J, Perea MA, del Romero J, Cano J, Hernando V, Bascones A. Oral transmission of HIV, reality or fiction? An update. Oral Dis 2006: 12: 219-228.
24. Castagnola M, Inzitari R, Rossetti DV, Olmi C, Cabras T, Piras V, Nicolussi P, Sanna MT, Pellegrini M, Giardina B, Messana I. A cascade of 24 histatins (histatin 3 fragments) in human saliva - suggestions for a pre-secretory sequential cleavage pathway. J Biol Chem 2004: 279: 41436-41443.
25. Choi S, Baik JE, Jeon JH, Cho K, Seo DG, Kum KY, Yun CH, Han SH. Identification of Porphyromonas gingivalis lipopolysaccharide-binding proteins in human saliva. Mol Immunol 2011: 48: 2207-2213.
26. Ciric L, Ellatif M, Sharma P, Patel R, Song X, Mullany P, Roberts AP. Tn916-like elements from human, oral, commensal streptococci possess a variety of antibiotic and antiseptic resistance genes. Int J Antimicrob Agents 2012: 39: 360-361.
27. Coats SR, Jones JW, Do CT, Braham PH, Bainbridge BW, To TT, Goodlett DR, Ernst RK, Darveau RP. Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1-and 4'-phosphatase activities. Cell Microbiol 2009: 11: 1587-1599.
28. Conti HR, Baker O, Freeman AF, Jang WS, Holland SM, Li RA, Edgerton M, Gaffen SL. New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome. Mucosal Immunol 2011: 4: 448-455.
29. Cuevas-Cordoba B, Santiago-Garcia J. Saliva: a fluid of study for OMICS. OMICS 2014: 18: 87-97.
30. Curtis MA, Percival RS, Devine D, Darveau RP, Coats SR, Rangarajan M, Tarelli E, Marsh PD. Temperature-dependent modulation of Porphyromonas gingivalis lipid A structure and interaction with the innate host defenses. Infect Immun 2011: 79: 1187-1193.
31. Davidopoulou S, Diza E, Menexes G, Kalfas S. Salivary concentration of the antimicrobial peptide LL-37 in children. Arch Oral Biol 2012: 57: 865-869.
32. de Haar SF, Hiemstra PS, van Steenbergen M, Everts V, Beertsen W. Role of polymorphonuclear leukocyte-derived serine proteinases in defense against Actinobacillus actinomycetemcomitans. Infect Immun 2006: 74: 5284-5291.
33. Devine DA. Cationic antimicrobial peptides in regulation of commensal and pathogenic microbial populations. In: Devine DA, Hancock REW, editors. Mammalian host defense peptides. Cambridge: Cambridge University Press, 2004: 9-37.
34. Devine DA, Cosseau C. Host defence peptides in the oral cavity. Adv Appl Microbiol 2008: 63: 281-322.
35. Devine DA, Marsh PD, Percival RS, Rangarajan M, Curtis MA. Modulation of antibacterial peptide activity by products of Porphyromonas gingivalis and Prevotella spp. Microbiology 1999: 145: 965-971.
36. Diamond G, Ryan LK. Beta-defensins: what are they REALLY doing in the oral cavity? Oral Dis 2011: 17: 628-635.
37. Diaz-Torres ML, Villedieu A, Hunt N, McNab R, Spratt DA, Allan E, Mullany P, Wilson M. Determining the antibiotic resistance potential of the indigenous oral microbiota of humans using a metagenomic approach. FEMS Microbiol Lett 2006: 258: 257-262.
38. Dixon DR, Jeffrey NR, Dubey VS, Leung KP. Antimicrobial peptide inhibition of Porphyromonas gingivalis 381-induced hemagglutination is improved with a synthetic decapeptide. Peptides 2009: 30: 2161-2167.
39. Dorschner RA, Lopez-Garcia B, Peschel A, Kraus D, Morikawa K, Nizet V, Gallo RL. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J 2006: 20: 35-42.
40. Fabian TK, Hermann P, Beck A, Fejérdy P, Fábián G. Salivary defense proteins: their network and role in innate and acquired oral immunity. Int J Mol Sci 2012: 13: 4295-4320.
41. Gibbons RJ, Hay DI, Childs WC 3rd, Davis G. Role of cryptic receptors (cryptitopes) in bacterial adhesion to oral surfaces. Arch Oral Biol 1990: 35(Suppl): 107s-114s.
42. Goncalves LD, Soares MR, Nogueira FCS, Garcia C, Camisasca DR, Domont G, Feitosa AC, Pereira Dde A, Zingali RB, Alves G. Comparative proteomic analysis of whole saliva from chronic periodontitis patients. J Proteomics 2010: 73: 1334-1341.
43. Gorr SU. Antimicrobial peptides of the oral cavity. Periodontol 2000 2009: 51: 152-180.
44. Gorr SU, Abdolhosseini M. Antimicrobial peptides and periodontal disease. J Clin Periodontol 2011: 38: 126-141.
45. Gutner M, Chaushu S, Balter D, Bachrach G. Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis. Infect Immun 2009: 77: 5558-5563.
46. Hannig C, Hannig M, Attin T. Enzymes in the acquired enamel pellicle. Eur J Oral Sci 2005: 113: 2-13.
47. Hardt M, Thomas LR, Dixon SE, Newport G, Agabian N, Prakobphol A, Hall SC, Witkowska HE, Fisher SJ. Toward defining the human parotid gland salivary proteome and peptidome: identification and characterization using 2D SDS-PAGE, ultrafiltration, HPLC, and mass spectrometry. Biochemistry 2005: 44: 2885-2899.
48. Hart TC, Hart PS, Bowden DW, Michalec MD, Callison SA, Walker SJ, Zhang Y, Firatli E. Mutations of the cathepsin C gene are responsible for Papillon-Lefevre syndrome. J Med Genet 1999: 36: 881-887.
49. Head D, Marsh P, Devine D. Non-lethal control of the cariogenic potential of an agent-based model for dental plaque. PLoS ONE 2014: 9: e105012.
50. Hell E, Giske CG, Nelson A, Römling U, Marchini G. Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis. Lett Appl Microbiol 2010: 50: 211-215.
51. Helmerhorst EJ, Oppenheim FG. The antifungal mechanisms of antimicrobial peptides. In: Devine DA, Hancock REW, editors. Mammalian host defense peptides. Cambridge: Cambridge University Press, 2004: 245-277.
52. Herp A, Wu AM, Moschera J. Current concepts of the structure and nature of mammalian salivary mucous glycoproteins. Mol Cell Biochem 1979: 23: 27-44.
53. Homer KA, Beighton D. Synergistic degradation of bovine serum albumin by mutans streptococci and other dental plaque bacteria. FEMS Microbiol Lett 1992: 69: 259-262.
54. Homer KA, Patel R, Beighton D. Effects of N-acetylglucosamine on carbohydrate fermentation by Streptococcus mutans NCTC 10449 and Streptococcus sobrinus SL-1. Infect Immun 1993: 61: 295-302.
55. Huq NL, Cross K, Ung M, Reynolds EC. A review of the salivary proteome and peptidome and saliva-derived peptide therapeutics. Int J Pept Res Ther 2007: 13: 547-564.
56. Jainkittivong A, Johnson DA, Yeh CK. The relationship between salivary histatin levels and oral yeast carriage. Oral Microbiol Immunol 1998: 13: 181-187.
57. Jones AH, Lee CC, Moncla BJ, Robinovitch MR, Birdsell DC. Surface 21 localization of sialic acid on Actinomyces viscosus. J Gen Microbiol 1986: 132: 3381-3391.
58. Jurevic RJ, Bai M, Chadwick RB, White TC, Dale BA. Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J Clin Microbiol 2003: 41: 90-96.
59. Kilian M, Mikkelsen L, Henrichsen J. Taxonomic studies of viridans streptococci: description of Streptococcus gordonii sp. nov. and emended descriptions of Streptococcus sanguis (White and Niven 1946), Streptococcus oralis (Bridge and Sneath 1982), and Streptococcus mitis (Andrewes and Horder 1906). Int J Syst Bacteriol 1989: 39: 471-484.
60. Klein A, Carnoy C, Wieruszeski JM, Strecker G, Strang AM, van Halbeek H, Roussel P, Lamblin G. The broad diversity of neutral and sialylated oligosaccharides derived from human salivary mucins. Biochemistry 1992: 31: 6152-6165.
61. Klier CM, Roble AG, Kolenbrander PE. Actinomyces serovar WVA963 coaggregation-defective mutant strain PK2407 secretes lactose-sensitive adhesin that binds to coaggregation partner Streptococcus oralis 34. Oral Microbiol Immunol 1998: 13: 337-340.
62. Koziel J, Karim AY, Przybyszewska K, Ksiazek M, Rapala-Kozik M, Nguyen KA, Potempa J. Proteolytic inactivation of LL-37 by karilysin, a novel virulence mechanism of Tannerella forsythia. J Innate Immun 2010: 2: 288-293.
63. Schenkels LC, Veerman EC, Niew Amerongen AV. Biochemical composition of human saliva in relation to other mucosal fluids. Crit Rev Oral Biol Med 1995: 6: 161-175.
64. Lee SH, Jun HK, Lee HR, Chung CP, Choi BK. Antibacterial and lipopolysaccharide (LPS)-neutralising activity of human cationic antimicrobial peptides against periodontopathogens. Int J Antimicrob Agents 2009: 35: 138-145.
65. Lee YH, Zimmerman JN, Custodio W, Xiao Y, Basiri T, Hatibovic-Kofman S, Siqueira WL. Proteomic evaluation of acquired enamel pellicle during in vivo formation. PLoS ONE 2013: 8: e67919.
66. Leito JT, Ligtenberg AJM, Nazmi K, Veerman EC. Identification of salivary components that induce transition of hyphae to yeast in Candida albicans. FEMS Yeast Res 2009: 9: 1102-1110.
67. Maiden MF, Tanner A, Macuch PJ. Rapid characterization of periodontal bacterial isolates by using fluorogenic substrate tests. J Clin Microbiol 1996: 34: 376-384.
68. Maisetta G, Batoni G, Esin S, Raco G, Bottai D, Favilli F, Florio W, Campa M. Susceptibility of Streptococcus mutans and Actinobacillus actinomycetemcomitans to bactericidal activity of human beta-defensin 3 in biological fluids. Antimicrob Agents Chemother 2005: 49: 1245-1248.
69. Maisetta G, Brancatisano FL, Esin S, Campa M, Batoni G. Gingipains produced by Porphyromonas gingivalis ATCC49417 degrade human-beta-defensin 3 and affect peptide's antibacterial activity in vitro. Peptides 2011: 32: 1073-1077.
70. Marsh P, Head D, Devine D. Prospects of oral disease control in the future - an opinion. J Oral Microbiol 2014: 6: 26176.
71. Mazda Y, Kawada-Matsuo M, Kanbara K, Oogai Y, Shibata Y, Yamashita Y, Miyawaki S, Komatsuzawa H. Association of CiaRH with resistance of Streptococcus mutans to antimicrobial peptides in biofilms. Mol Oral Microbiol 2012: 27: 124-135.
72. McNab R, Holmes AR, Clarke JM, Tannock GW, Jenkinson HF. Cell surface polypeptide CshA mediates binding of Streptococcus gordonii to other oral bacteria and to immobilized fibronectin. Infect Immun 1996: 64: 4204-4210.
73. Moncla BJ, Braham P, Hillier SL. Sialidase (neuraminidase) activity among gram-negative anaerobic and capnophilic bacteria. J Clin Microbiol 1990: 28: 422-425.
74. Moncla BJ, Braham P, Rabe LK, Hillier SL. Rapid presumptive identification of black-pigmented gram-negative anaerobic bacteria by using 4-methylumbelliferone derivatives. J Clin Microbiol 1991: 29: 1955-1958.
75. Mookherjee N, Brown KL, Bowdish DME, Doria S, Falsafi R, Hokamp K, Roche FM, Mu R, Doho GH, Pistolic J, Powers JP, Bryan J, Brinkman FS, Hancock RE. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol 2006: 176: 2455-2464.
76. Nobbs AH, Lamont RJ, Jenkinson HF. Streptococcus adherence and colonization. Microbiol Mol Biol Rev 2009: 73: 407-450.
77. Oudhoff MJ, Blaauboer ME, Nazmi K, Scheres N, Bolscher JG, Veerman EC. The role of salivary histatin and the human cathelicidin LL-37 in wound healing and innate immunity. Biol Chem 2010: 391: 541-548.
78. Overhage J, Campisano A, Bains M, Torfs EC, Rehm BH, Hancock RE. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 2008: 76: 4176-4182.
79. Ozturk A, Famili P, Vieira AR. The antimicrobial peptide DEFB1 is associated with caries. J Dent Res 2010: 89: 631-636.
80. Pan Y, Rowney M, Guo P, Hobman P. Biological properties of lactoferrin: an overview. Aust J Dairy Technol 2007: 62: 31-42.
81. Peschel A, Sahl HG. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol 2006: 4: 529-536.
82. Phattarataratip E, Olson B, Broffitt B, Qian F, Brogden KA, Drake DR, Levy SM, Banas JA. Streptococcus mutans strains recovered from caries-active or caries-free individuals differ in sensitivity to host antimicrobial peptides. Mol Oral Microbiol 2011: 26: 187-199.
83. Preza D, Thiede B, Olsen I, Grinde B. The proteome of the human parotid gland secretion in elderly with and without root caries. Acta Odontol Scand 2009: 67: 161-169.
84. Putsep K, Carlsson G, Boman HG, Andersson M. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 2002: 360: 1144-1149.
85. Quintana M, Palicki O, Lucchi G, Ducoroy P, Chambon C, Salles C, Morzel M. Inter-individual variability of protein patterns in saliva of healthy adults. J Proteomics 2009: 72: 822-830.
86. Rane V. Interactions between innate defence molecules and oral biofilms. PhD Thesis, University of Leeds, UK, 2006.
87. Rosen G, Sela MN, Bachrach G. The antibacterial activity of LL-37 against Treponema denticola is dentilisin protease independent and facilitated by the major outer sheath protein virulence factor. Infect Immun 2012: 80: 1107-1114.
88. Ruhl S, Sandberg AL, Cisar JO. Salivary receptors for the proline-rich protein-binding and lectin-like adhesins of oral actinomyces and streptococci. J Dent Res 2004: 83: 505-510.
89. Saar-Dover R, Bitler A, Nezer R, Shmuel-Galia L, Firon A, Shimoni E, Trieu-Cuot P, Shai Y. D-alanylation of lipoteichoic acids confers resistance to cationic peptides in group b streptococcus by increasing the cell wall density. PLoS Pathog 2012: 8: e1002891.
90. Schaefer AS, Richter GM, Nothnagel M, Laine ML, Rühling A, Schäfer C, Cordes N, Noack B, Folwaczny M, Glas J, Dörfer C, Dommisch H, Groessner-Schreiber B, Jepsen S, Loos BG, Schreiber S. A 3 'UTR transition within DEFB1 is associated with chronic and aggressive periodontitis. Genes Immun 2010: 11: 45-54.
91. Schwalfenberg GK. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutrit Food Res 2011: 55: 96-108.
92. Scott MG, Rosenberger CM, Gold MR, Finlay BB, Hancock RE. An alpha-helical cationic antimicrobial peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression. J Immunol 2000: 165: 3358-3365.
93. Semple F, MacPherson H, Webb S, Cox SL, Mallin LJ, Tyrrell C, Grimes GR, Semple CA, Nix MA, Millhauser GL, Dorin JR. Human beta-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF. Eur J Immunol 2011: 41: 3291-3300.
94. Shankar EM, Velu V, Vignesh R, Vijayaraghavalu S, Rukumani DV, Sabet NS. Recent advances targeting innate immunity-mediated therapies against HIV-1 infection. Microbiol Immunol 2012: 56: 497-505.
95. Shelburne CE, Coulter WA, Olguin D, Lantz MS, Lopatin DE. Induction of beta-defensin resistance in the oral anaerobe Porphyromonas gingivalis. Antimicrob Agents Chemother 2005: 49: 183-187.
96. Shimotoyodome A, Kobayashi H, Tokimitsu I, Matsukubo T, Takaesu Y. Statherin and histatin 1 reduce parotid saliva-promoted Streptococcus mutans strain MT8148 adhesion to hydroxyapatite surfaces. Caries Res 2006: 40: 403-411.
97. Soares MS, Batista-Filho MM, Pimentel MJ, Passos IA, Chimenos-Küstner E. Determination of salivary glucose in healthy adults. Med Oral Patol Oral Cir Bucal 2009: 14: e510-e513.
98. Soares RV, Lin T, Siqueira CC, Bruno LS, Li X, Oppenheim FG, Offner G, Troxler RF. Salivary micelles: identification of complexes containing MG2, slgA, lactoferrin, amylase, glycosylated proline-rich protein and lysozyme. Arch Oral Biol 2004: 49: 337-343.
99. Sorensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, Hiemstra PS, Borregaard N. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001: 97: 3951-3959.
100. Steinstraesser L, Kraneburg U, Jacobsen F, Al-Benna S. Host defense peptides and their antimicrobial-immunomodulatory duality. Immunobiology 2011: 216: 322-333.
101. Tao RC, Jurevic RJ, Coulton KK, Tsutsui MT, Roberts MC, Kimball JR, Wells N, Berndt J, Dale BA. Salivary antimicrobial peptide expression and dental caries experience in children. Antimicrob Agents Chemother 2005: 49: 3883-3888.
102. Tarelli E, Byers HL, Homer KA, Beighton D. Evidence for mannosidase activities in Streptococcus oralis when grown on glycoproteins as carbohydrate source. Carbohydr Res 1998: 312: 159-164.
103. ter Steeg PF, van der Hoeven JS, de Jong MH, van Munster PJ, Jansen MJH. Enrichment of subgingival microflora on human serum leading to accumulation of Bacteroides species, peptostreptococci and fusobacteria. Antonie Van Leeuwenhoek 1987: 53: 261-272.
104. Troeltzsch M, Pache C, Probst FA, Troeltzsch M, Ehrenfeld M, Otto S. Antibiotic concentrations in saliva: a systematic review of the literature, with clinical implications for the treatment of sialadenitis. J Oral Maxillofac Surg 2014: 72: 67-75.
105. Tsai PW, Yang CY, Chang HT, Lan CY. Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates. PLoS ONE 2011: 6: e17755.
106. van Hoek AHAM, Mevius D, Guerra B, Mullany P, Roberts AP, Aarts HJ. Acquired antibiotic resistance genes: an overview. Front Microbiol 2011: 2: 203.
107. Vimr E, Lichtensteiger C, Steenbergen S. Sialic acid metabolism's dual function in Haemophilus influenzae. Mol Microbiol 2000: 36: 1113-1123.
108. Vitorino R, Barros A, Caseiro A, Domingues P, Duarte J, Amado F. Towards defining the whole salivary peptidome. Proteomics Clin Applic 2009: 3: 528-540.
109. Vitorino R, Lobo MJC, Duarte JR, Ferrer-Correia AJ, Domingues PM, Amado FM. The role of salivary peptides in dental caries. Biomed Chromatogr 2005: 19: 214-222.
110. Wakabayashi H, Yamauchi K, Kobayashi T, Yaeshima T, Iwatsuki K, Yoshie H. Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia. Antimicrob Agents Chemother 2009: 53: 3308-3316.
111. Wei GX, Campagna AN, Bobek LA. Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J Antimicrob Chemother 2006: 57: 1100-1109.
112. White MR, Helmerhorst EJ, Ligtenberg A, Karpel M, Tecle T, Siqueira WL, Oppenheim FG, Hartshorn KL. Multiple components contribute to ability of saliva to inhibit influenza viruses. Oral Microbiol Immunol 2009: 24: 18-24.
113. Zalewska A, Knas M, Kuzmiuk A, Waszkiewicz N, Niczyporuk M, Waszkiel D, Zwierz K. Salivary innate defense system in type 1 diabetes mellitus in children with mixed and permanent dentition. Acta Odontol Scand 2013: 71: 1493-1500.
114. Zeng L, Das S, Burne RA. Utilization of lactose and galactose by Streptococcus mutans: transport, toxicity, and carbon catabolite repression. J Bacteriol 2010: 192: 2434-2444.